Follow The Filings

IDXX Idexx Laboratories

Idexx Laboratories earnings company data as of 5:07 PM ET 10/30

  • 1 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 2 Nov EPS 3.71 — —
Rev $1.19B — —
FY2026 Q2 4 Aug EPS 3.95 4.27 Beat +8.1%
Rev — — —

Insider trades

Open-market buys and sales by IDXX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IDXX insider trades
  • None no insider bought on the open market
  • $37.7M sold by 6 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Lawrence D Kingsley Director
    Sale
    $1.2M 2,203 shares at $532.08 19% of stake
    Traded Sep 4 Filed Sep 9
  2. Nimrata Hunt Executive Vice President
    Sale
    $1.1M 1,758 shares at $634.57 8.8% of stake
    Traded Mar 3 Filed Mar 5
  3. Jonathan Jay Mazelsky CEO
    Sale
    $15.3M 23,326 shares at $657.55 22% of stake
    Traded Feb 26 Filed Mar 2
  4. Nimrata Hunt Executive Vice President
    Sale
    $1.8M 2,693 shares at $661.54 12% of stake
    Traded Feb 26 Filed Feb 27
  5. Michael G Erickson Executive Vice President
    Sale
    $3.4M 5,371 shares at $627.38 30% of stake
    Traded Feb 17 Filed Feb 19
  6. Sophie V. Vandebroek Director
    Sale
    $920K 1,464 shares at $628.62 69% of stake
    Traded Feb 17 Filed Feb 19
  7. George Fennell Executive Vice President
    Sale
    $7.3M 11,345 shares at $646.72 54% of stake
    Traded Feb 10 Filed Feb 11
  8. Nimrata Hunt Executive Vice President
    Sale
    $6.6M 9,425 shares at $703.34 31% of stake
    Traded Nov 7, 2025 Filed Nov 10, 2025

Also filed in the last 12 months, not counted as buying or selling: 67 option exercises, 12 share withholdings for taxes, and 4 stock grants.

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
8-K 5.03,5.07,9.01
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G/A —
DEF 14A
DEFA14A
8-K 5.02,9.01
10-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.